Hudock Inc’s Guardant Health GH Stock Holding History

Hudock Inc’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-150	Closed	-$6K	–	770
2022 Q2	$6K	Hold	150	–	–	﹤0.01%	568
2022 Q1	$9K	Hold	150	–	–	﹤0.01%	550
2021 Q4	$15K	Hold	150	–	–	﹤0.01%	485
2021 Q3	$18K	Hold	150	–	–	0.01%	462
2021 Q2	$18K	Hold	150	–	–	0.01%	463
2021 Q1	$22K	Hold	150	–	–	0.01%	429
2020 Q4	$19K	Hold	150	–	–	0.01%	435
2020 Q3	$16K	Hold	150	–	–	0.01%	408
2020 Q2	$12K	Hold	150	–	–	﹤0.01%	426
2020 Q1	$10K	Hold	150	–	–	﹤0.01%	397
2019 Q4	$11K	Buy	+150	New	+$10.8K	﹤0.01%	411

Other funds holding GH

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Hudock Inc's GH Position: Q3 2022 in Review

Hudock Inc sold out of Guardant Health (GH) in Q3 2022, closing a stake of 150 shares — an estimated $6K sold.

Hudock Inc first reported a position in GH in Q4 2019 and held it in 11 quarters. The position peaked at $22K in Q1 2021. 328 funds tracked by Wall St. Rank hold GH as of Q3 2022.

Hudock Inc reported no remaining Guardant Health position as of Q3 2022 after selling out during the quarter.
Hudock Inc sold 150 Guardant Health shares in Q3 2022, an estimated $6K.
Hudock Inc first reported a position in Guardant Health in Q4 2019 and held it in 11 quarters.
Hudock Inc's Guardant Health position peaked at $22K in Q1 2021.
328 funds tracked by Wall St. Rank held Guardant Health as of Q3 2022.

Based on Hudock Inc's 13F filing for Q3 2022, filed 2 Nov 2022.